Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 15, 2022 - Issue
Submit an article Journal homepage
127
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Next-Generation Sequencing and Bioinformatics-Based Protocol for the Full-Length CYP2E1 Gene Polymorphism Analysis

Viktorija Igumnova1 Molecular Microbiology Group, Latvian Biomedical Research and Study Centre, Riga, Latvia;2 Department of Pharmaceutical Chemistry, Riga Stradins University, Riga, LatviaORCID Iconhttps://orcid.org/0000-0002-5028-2718View further author information
ORCID Icon,
Agnija Kivrane1 Molecular Microbiology Group, Latvian Biomedical Research and Study Centre, Riga, Latvia;2 Department of Pharmaceutical Chemistry, Riga Stradins University, Riga, LatviaORCID Iconhttps://orcid.org/0000-0002-8284-2011View further author information
ORCID Icon,
Anda Viksna3 Department of Infectology, Riga Stradins University, Riga, Latvia;4 Centre of Tuberculosis and Lung Diseases, Riga East University Hospital, Riga, LatviaView further author information
,
Inga Norvaisa4 Centre of Tuberculosis and Lung Diseases, Riga East University Hospital, Riga, LatviaView further author information
&
Renate Ranka1 Molecular Microbiology Group, Latvian Biomedical Research and Study Centre, Riga, Latvia;2 Department of Pharmaceutical Chemistry, Riga Stradins University, Riga, LatviaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3716-7950View further author information
ORCID Icon
Pages 959-965 | Received 21 Apr 2022, Accepted 07 Oct 2022, Published online: 08 Nov 2022

References

  • Stanford University and St. Jude Children’s Research Hospital. Clinical pharmacogenetics implementation consortium guidelines. Available from: https://cpicpgx.org/guidelines/. Accessed October 31, 2022.
  • Zhou Y, Ingelman-Sundberg M, Lauschke VM. Worldwide distribution of cytochrome P450 alleles: a meta-analysis of population-scale sequencing projects. Clin Pharmacol Ther. 2017;102(4):688–700. doi:10.1002/cpt.690
  • Goh LL, Lim CW, Sim WC, Toh LX, Leong KP, Ahmad A. Analysis of genetic variation in CYP450 genes for clinical implementation. PLoS One. 2017;12(1):e0169233. doi:10.1371/journal.pone.0169233
  • Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138:103–141. doi:10.1016/j.pharmthera.2012.12.007
  • Danielson PB. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab. 2002;3(6):561–597. doi:10.2174/1389200023337054
  • Guengerich FP. Cytochrome P450 2E1 and its roles in disease. Chem Biol Interact. 2020;322:109056. doi:10.1016/j.cbi.2020.109056
  • Ronis MJJ, Lindros KO, Ingelman-Sundberg M. The CYP2E subfamily. In: Ioannides C, Parke DV, editors. Cytochromes P450, Metabolic and Toxicological Aspects. Boca Raton: CRC Press; 1996:211–239.
  • Harjumäki R, Pridgeon CS, Ingelman-Sundberg M. CYP2E1 in alcoholic and non-alcoholic liver injury. Roles of ROS, reactive intermediates and lipid overload. Int J Mol Sci. 2021;22(15):8221. doi:10.3390/ijms22158221
  • Na HK, Lee JY. Molecular basis of alcohol-related gastric and colon cancer. Int J Mol Sci. 2017;18(6):1116. doi:10.3390/ijms18061116
  • Whirl-Carrillo M, Huddart R, Gong L, et al. An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther. 2021;110(3):563–572. doi:10.1002/cpt.2350
  • Rovite V, Wolff-Sagi Y, Zaharenko L, Nikitina-Zake L, Grens E, Klovins J. Genome Database of the Latvian population (LGDB): design, goals, and primary results. J Epidemiol. 2018;28(8):353–360. doi:10.2188/jea.JE20170079
  • Kivrane A, Igumnova V, Kimsis J, et al. Implementation of a next-generation sequencing-based targeted approach for full-length CYP3A4 gene sequencing. Pharmacogenomics. 2021;22(9):519–527. doi:10.2217/pgs-2020-0128
  • Jalili V, Afgan E, Gu Q, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2020 update. Nucleic Acids Res. 2020;48(W1):W395–W402. doi:10.1093/nar/gkaa434
  • Robinson J, Thorvaldsdóttir H, Winckler W, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–26. doi:10.1038/nbt.1754
  • Yang H, Wang K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat Protoc. 2015;10(10):1556–1566. doi:10.1038/nprot.2015.105
  • National Center for Biotechnology Information, National Library of Medicine. Database of Single Nucleotide Polymorphisms (dbSNP). Available from: http://www.ncbi.nlm.nih.gov/SNP/. Accessed October 31, 2022.
  • Comuzzie AG, Cole SA, Laston SL, et al. Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One. 2012;7(12):e51954. doi:10.1371/journal.pone.0051954
  • Iacobucci I, Lonetti A, Candoni A, et al. Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. Pharmacogenomics J. 2013;13(4):335–341. doi:10.1038/tpj.2012.13
  • Chen K, Guo R, Wei C. Synonymous mutation rs2515641 affects CYP2E1 mRNA and protein expression and susceptibility to drug-induced liver injury. Pharmacogenomics. 2020;21(7):459–470. doi:10.2217/pgs-2019-0151
  • Yu Y, Tsao S-M, Yang W-T, et al. Association of drug metabolic enzyme genetic polymorphisms and adverse drug reactions in patients receiving rifapentine and isoniazid therapy for latent tuberculosis. Int J Environ Res Public Health. 2019;17(1):210. doi:10.3390/ijerph17010210
  • Hlaváč V, Holý P, Souček P. Pharmacogenomics to predict tumor therapy response: a focus on ATP-binding cassette transporters and cytochromes P450. J Pers Med. 2020;10(3):108. PMID: 32872162; PMCID: PMC7565825. doi:10.3390/jpm10030108
  • Khrunin A, Ivanova F, Moisseev A, et al. Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins. Pharmacogenomics. 2012;13:171–178. doi:10.2217/pgs.11.140
  • García-Suástegui WA, Ramos-Chávez LA, Rubio-Osornio M, et al. The role of CYP2E1 in the drug metabolism or bioactivation in the brain. Oxid Med Cell Longev. 2017;2017:4680732. doi:10.1155/2017/4680732

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.